Scientists Discover an Umami Peptide from Sea Cucumber That Also Fights Inflammation in Cells

Sea cucumber has long occupied a curious place at the intersection of food and medicine in East Asia, prized as a collagen-rich delicacy with purported health benefits. Now a team of Chinese researchers has taken that reputation into the laboratory and emerged with something remarkable: a single five-amino-acid peptide, carved out of sea cucumber protein, that tastes strikingly like monosodium glutamate and simultaneously dampens inflammatory signaling in immune cells. The study, published in Food Chemistry: X, weaves together flavoromics, mass spectrometry, bioinformatic prediction, molecular simulation, and cell experiments into one of the most complete pipelines yet assembled for hunting down food-derived peptides that are both delicious and biologically active.

The motivation is industrial as much as scientific. China’s annual aquaculture yield of fresh sea cucumber exceeds 220,000 tons, generating enormous quantities of protein-rich raw material that conventional processing methods such as drying and rehydration fail to exploit at high value. The researchers, led by Zhongxing Chu of Central South University of Forestry and Technology and colleagues, reasoned that enzymatic hydrolysis could unlock that value in two directions at once: releasing short bioactive peptides with immunomodulatory potential while also reshaping the flavor profile of the resulting ingredient. What has been missing in prior work, they argue, is a systematic account of how protein structure, flavor chemistry, and peptide bioactivity are connected under a defined hydrolysis process.

To make that connection, the team subjected sea cucumber protein with a purity above 90 percent and a collagen content above 82 percent to a sequential three-enzyme digestion using pepsin, trypsin, and enterokinase, each applied at an enzyme-to-substrate ratio of 1 percent for four hours at 37 degrees Celsius. The treatment cleaved roughly 40.72 percent of the available peptide bonds, as measured by the o-phthalaldehyde colorimetric method, producing a hydrolysate dominated by short fragments. A parallel blank control without added enzymes ruled out interference from endogenous proteases in the raw material, ensuring that the observed transformations could be attributed to the deliberate enzymatic process.

The structural consequences of that digestion were documented with an unusually thorough battery of techniques. Scanning electron microscopy revealed that the native protein, an irregular and densely packed sheet-like material with smooth surfaces, was transformed into a porous, sponge-like network riddled with interconnected cavities. Fourier-transform infrared spectroscopy showed a decline in ordered alpha-helical content and a rise in random coil structures, while ultraviolet and fluorescence spectroscopy demonstrated that aromatic amino acids buried in the hydrophobic core had been exposed to the aqueous environment, with the tryptophan emission peak red-shifting from about 330 to 345 nanometers. X-ray diffraction and differential scanning calorimetry completed the picture: the hydrolysate lost the cooperative thermal denaturation behavior characteristic of intact proteins, meaning the small peptides are less prone to coagulation during food processing, a practical advantage for manufacturers.

Flavor, often treated as an afterthought in peptide research, received full analytical attention here. Using headspace solid-phase microextraction coupled with gas chromatography on an Orbitrap mass spectrometer, the team identified 147 significantly differential volatile compounds between the native protein and the hydrolysate, with 74 upregulated after digestion. Aldehydes such as hexanal and (E,E)-2,4-nonadienal, products of unsaturated fatty acid oxidation, drove the green and fatty notes, while heterocyclic compounds including 2-pentylfuran and trimethylpyrazine, likely born of Maillard reactions between newly liberated amino groups and trace reducing sugars, contributed fried and waxy aromas. The multivariate statistical models separating the two sample groups passed rigorous validation with 200 permutation tests, lending confidence to the conclusion that hydrolysis fundamentally remodeled the volatile landscape of the ingredient.

Peptide identification by liquid chromatography tandem mass spectrometry revealed roughly 9.5 amino acids as the average chain length, with most peptides falling between 0.5 and 1.5 kilodaltons, a size range favorable for intestinal absorption. Glycine and glutamine or glutamic acid dominated the amino acid composition, each exceeding 13 percent average abundance, a signature of the (Gly-X-Y) repeating motif of collagen and direct confirmation that the peptides derived from sea cucumber collagen. The peptides were overwhelmingly hydrophilic and weakly acidic, properties that improve dispersibility in aqueous food systems and reduce precipitation, and the high confidence scores of the identifications underscored the reliability of the dataset.

The screening stage is where the study’s integrative design paid off. From the mass spectrometric sequences, the researchers applied a cascade of computational tools: umami and bitterness predictors, the PeptideRanker bioactivity server, a CSM-peptides immunomodulatory model, and safety checks for toxicity, allergenicity, and water solubility. Sixteen high-confidence peptides emerged, and three candidates, FDRGF, CPPGFMG, and FFSLFCLL, cleared the thresholds of umami probability of at least 0.23, bioactivity score of at least 0.97, and non-toxic, non-bitter status. An electronic tongue then arbitrated. FDRGF, a pentapeptide with the sequence phenylalanine-aspartic acid-arginine-glycine-phenylalanine, posted an umami response of 78, second only to monosodium glutamate at 85, with minimal bitterness and astringency. CPPGFMG showed kokumi-like characteristics reminiscent of glutathione, while FFSLFCLL was undermined by noticeable bitterness. FDRGF, with the highest umami probability of 0.557 and an anti-inflammatory score of 0.78, was crowned the dual-function lead candidate.

Computational docking against three key inflammatory targets, tumor necrosis factor, AKT1, and interleukin-1 beta, predicted favorable binding for all three, with the strongest affinity for AKT1 at a binding energy of minus 9.9 kilocalories per mole. One-hundred-nanosecond molecular dynamics simulations in GROMACS confirmed that the complexes remained stable, with root mean square deviation curves converging to the 1 to 3 angstrom range and residues at the binding interface showing reduced flexibility, a sign of specific and durable engagement. These simulations, the authors note, bridge the gap between static docking snapshots and the dynamic behavior of proteins under physiological conditions, providing structural plausibility for the peptide’s presumed mechanism of interfering with inflammatory cascade initiation.

The decisive test came in RAW 264.7 macrophages, a standard mouse immune cell line. At concentrations from 6.25 to 100 micrograms per milliliter, the peptide showed no cytotoxicity, with viability remaining above 95.28 percent. When the cells were challenged with lipopolysaccharide, a bacterial toxin that drives viability down to about 84 percent and triggers classic inflammatory damage, pre-treatment with the peptide restored metabolic activity in a dose-dependent manner, peaking at 50 micrograms per milliliter. Microscopy showed cells recovering their healthy, spread-out macrophage morphology with visible pseudopodia. More tellingly, the peptide dose-dependently reduced intracellular reactive oxygen species, suppressed NF-kappa-B transcriptional activity in a dual-luciferase reporter assay, and downregulated the protein expression of interleukin-1 beta, tumor necrosis factor alpha, interleukin-6, and the inflammatory enzyme COX-2, the molecular machinery of inflammation itself.

The authors are candid about the limits of their evidence. The immunological findings rest entirely on an in vitro macrophage model of lipopolysaccharide-induced injury, which captures anti-inflammatory performance under stress but cannot represent the full sweep of innate and adaptive immune regulation, and the MTS assay measures metabolic activity rather than complete immune function recovery. Quantitative peptide yield and conversion efficiency were also not determined at this stage. Still, the study stands as a template for how modern food science can pursue two goals at once: an ingredient that delights the palate and, at least in cell culture, calms the inflammatory response. Whether the five-letter peptide FDRGF can carry that promise from the petri dish to the dinner plate will depend on animal and human studies, but as a proof of concept for flavor-functional peptides from underexploited marine protein, it is a savory result in every sense.

Subject of Research: Identification of an umami-tasting, anti-inflammatory peptide from enzymatically hydrolyzed sea cucumber protein

Article Title: Screening and identification of a novel umami peptide with in vitro anti-inflammatory potential from sea cucumber protein: Integration of flavoromics, bioinformatic prediction, molecular simulation and experimental validation

Article References: Chu, Z., Long, C., Xu, K., Zhang, X., Qin, D., Hu, Z., Zhou, Y., Luo, F., & Lin, Q. (2026). Screening and identification of a novel umami peptide with in vitro anti-inflammatory potential from sea cucumber protein: Integration of flavoromics, bioinformatic prediction, molecular simulation and experimental validation. Food Chemistry: X, 39, Article 104580. https://doi.org/10.1016/j.fochx.2026.104580

Image Credits: AI Generated

DOI: 10.1016/j.fochx.2026.104580

Keywords: sea cucumber, umami peptide, bioactive peptides, enzymatic hydrolysis, anti-inflammatory, flavoromics, molecular docking, molecular dynamics, RAW 264.7 macrophages, NF-kappa-B, collagen, food chemistry